Twist Bioscience (TWST) shares were up 17% in afternoon trading on Wednesday after the company said it was selected by Anthropic as an independent evaluator for a multi-arm protein design project using artificial intelligence.
Twist was one of those chosen to rapidly produce at scale the AI-designed proteins and test the designs for binding, the company said in a regulatory filing.
Price: 136.02, Change: +19.92, Percent Change: +17.16
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments